December 16, 2020
1 min watch
Save
VIDEO: Treatment advances in HER2 metastatic breast cancer
Nancy U. Lin, MD, spoke with Healio about the advances and challenges in the treatment of HER2-positive metastatic breast cancer.
“We’ve made tremendous progress since the development of HER2-based therapies,” Lin, an associate professor at Harvard Medical School and clinical director of the Breast Oncology Center at Dana-Farber Cancer Institute, said in her recap of her presentation from the San Antonio Breast Cancer Symposium.
Published by:
Sources/Disclosures
Collapse
Source:
Lin NU. Abstract ES7. Presented at: San Antonio Breast Cancer Symposium (Virtual); Dec. 8-11, 2020.
Disclosures:
Lin reports serving as a consultant with AstraZeneca and receiving grant support from Genentech and Seattle Genetics.